Caesars Entertainment, GenMark, Eli Lilly: What to Watch When the | Sidnaz Blog

Here’s what we’re watching ahead of Monday’s opening bell.

U.S. stock futures edged higher, suggesting that the major indexes will extend their rally after both the Dow Jones Industrial Average and the S&P 500 closed last week at a record.

Dow futures rose 0.4%, suggesting that blue-chip stocks in companies sensitive to the economic recovery will extend their gains. Contracts tied to the S&P 500 edged up 0.3%. Nasdaq-100 futures ticked 0.3% higher, pointing to muted gains for the technology sector. Read our full market wrap.

What’s Coming Up

Earnings are due from Accel Entertainment and Desktop Metal before the open.

Westport Fuel Systems


WPRT 2.20%

is scheduled to report after the close.

The New York Fed’s Empire State manufacturing survey for March, due at 8:30 a.m. ET, is expected to rise to 15 from 12.1 a month earlier.

Market Movers to Watch

Eli Lilly


LLY 1.40%

shares dropped 4.4% premarket. An experimental drug from the pharmaceutical firm modestly slowed the cognitive and functional decline of early-stage Alzheimer’s patients over 18 months in a small, midstage clinical study.

GenMark Diagnostics


GNMK 0.19%

shares jumped 29% ahead of the bell.

Roche Holding


RHHBY -1.56%

said Monday that it signed a definitive merger agreement with GenMark in a deal valued at approximately $1.8 billion on a fully diluted basis.

—Shares of

Caesars Entertainment


CZR -0.13%

climbed 6.3% premarket. S&P Indices said late Friday that the casino operator would be added to the S&P 500 effective March 22.

The. Caesars Palace hotel and casino in Las Vegas, Nevada, U.S., July 28, 2020.



Photo:

Roger Kisby/Bloomberg News

Tesla


TSLA -0.84%

shares edged down 0.4% premarket, as investors offered a frosty shoulder to Chief Executive

Elon Musk

‘s new official title, “Technoking of Tesla.” Finance Chief

Zach Kirkhorn

was given the title “Master of Coin”—though both men will also retain their traditional C-suite positions.

Market Fact

—A broad index of pharmaceutical stocks has underperformed the S&P 500 by 6 percentage points so far this year.

Chart of the Day

In the coming months, banks are expected to free up tens of billions of dollars in reserves they set aside to cover soured loans—losses that still haven’t materialized a year into the pandemic.

Must Reads Since You Went to Bed

Minority-Owned Investment Banks Are Underwriting More Corporate Bond Offerings

Electric-Vehicle Startups Promise Record-Setting Revenue Growth

Fintech Stripe Scores Blockbuster $95 Billion Valuation

Yellen Says Biden Administration Undecided on Wealth Tax

Copyright ©2020 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: